Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
151-177
Author(s):
S. Rutella, G. Bonanno and R. De Cristofaro
Yeast-Derived β-Glucan in Combination with Anti-Tumor Monoclonal Antibody Therapy in Cancer
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
4
Page:
101-109
Author(s):
Jingjing Liu, Lacey Gunn, Richard Hansen and Jun Yan
Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
4
Page:
110-124
Author(s):
Yu-Wen E. Chang, Ronald R. Bean and Rolf Jakobi
Paving Roads for New Drugs in Oncology
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
4
Page:
137-145
Author(s):
Kurt S. Zaenker and Frank Entschladen
Anti-Angiogenic Agents and Cancer: Current Insights and Future Perspectives
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
4
Page:
180-185
Author(s):
Boel De Paepe
3-Hydroxy-2-phenyl-4(1H)-quinolinones as Promising Biologically Active Compounds
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
9
Page:
696-702
Author(s):
P. Hradil, J. Hlavac, M. Soural, M. Hajduch, M. Kolar and R. Vecerova
RNA Interference in Cancer: Targeting the Anti-Apoptotic Protein c-FLIP for Drug Discovery
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
9
Page:
741-748
Author(s):
Travis W. Day and Ahmad R. Safa
Retracted: Potential Health Benefits of Broccoli- A Chemico-Biological Overview
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
9
Page:
749-759
Author(s):
Hannah R. Vasanthi, Subhendu Mukherjee and Dipak K. Das
Discovery of 8-methoxypyrazino[1,2-a]indole as a New Potent Antiproliferative Agent Against Human Leukemia K562 Cells. A Structure-Activity Relationship Study
Journal:
Letters in Drug Design & Discovery
Volume:
6
Page:
298-303
Author(s):
Romeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, Olga Cruz-Lopez, Carlota Lopez Cara, Delia Preti, Mojgan Aghazadeh Tabrizi, Jan Balzarini, Ernest Hamel, Enrica Fabbri and Roberto Gambari
Use of Pre-Clinical In Vitro and In Vivo Pharmacokinetics for the Selection of a Potent Hepatitis C Virus Protease Inhibitor, Boceprevir, for Clinical Development
Journal:
Letters in Drug Design & Discovery
Volume:
6
Page:
312-318
Author(s):
K.-C. Cheng, Cheng Li, Tongtong Liu, Ganfeng Wang, Yunsheng Hsieh, Anastasia Pavlosky, Lisa Broske, Dan Prelusky, Rong Liu, Ronald E. White, Annette S. Uss, Samir Gupta and F. George Njoroge